Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Tulane Educational Fund is a private company headquartered in the United States specializing in radio broadcasting stations.

Red Bull GmbH engages in the development and production of energy drinks. Its product portfolio includes Red Bull Energy Drink, Red Bull Sugarfree, Red Bull Zero Calories, Red Bull White Edition, Red Bull Blue Edition, Red Bull Lime Edition, Red Bull Green Edition, Red Bull Yellow Edition, and Red Bull Summer Edition. The firm also sponsors and produces sports events like surfing, motor sports, hockey, football, sailing, and Esports. The company was founded by Dietrich Mateschitz in 1984 and is headquartered in Fuschl am See, Austria.

Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

Zhengzhou Huamei Color Printing & Paper Products Co. Ltd. is a company headquartered in Zhengzhou, China and ultimately controlled by the Government of China. The firm produces color printed paper boxes and labels.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Changzhou Haolilai Photoelectric Technology Co., Ltd., established on 1998-09-22, Business scope includes research and development of optical systems;optical lens,Manufacturing of optical instruments and accessories;Semiconductor material processing;laser cutter,laser engraving machine,laser welding machine,Development of optical instruments and accessories,Production,Sales;Sales of laser equipment and laser products;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bofu--Ipsen (Tianjin) Pharmaceutical Co., Ltd., established on 1997-04-08, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug import and export;Class III medical device business;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-residential real estate leases;housing lease;Import and export;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;Financial Advisory;Supply Chain Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hefei Bailvsheng Agricultural Technology Co., Ltd., established on 2017-05-09, Business scope includes general items:Research and development of technology for the harmless utilization of agricultural and forestry waste resources;Agricultural non-point source and heavy metal pollution prevention and control technical services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Internet of things technology research and development;Wholesale Fresh Vegetables;Fresh Fruit Wholesale;Wholesale of edible agricultural products;gift flower sale;Gardening Product Sales;Bazaar management services;Leasing and management of flowers and green plants;Agriculture and Gardening Services;Tourism development project planning consultation;Information Consulting Service(Not including licensing information consulting services)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Chongqing Ziguang International Chemical Co., Ltd., established on 2007-10-22, Business scope includes licensed projects:Hazardous Chemical Production(Engage in business according to the approved items and time limit of the license);Import and export of goods and technology(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Chemical products and chemical raw materials(Does not contain hazardous chemicals other than those approved and approved)research and development,Production,Sales;Technical services in the chemical industry,technical consulting,technology transfer;Development of pharmaceutical intermediates,to develop;Environmental protection and energy saving products,Chemical automation equipment,Chemical Equipment,Technology transfer of environmental protection equipment,Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Lingbi County Tongshifu Food Co., Ltd., established on 2014-11-12, Business scope includes prepackaged food,cum bulk food,dairy sales;Sales of agricultural and sideline products

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Anhui Suoya Decoration Materials Co., Ltd., established on 2012-07-13, Business scope includes decorative materials,Glass product,Research and development of explosion-proof membrane and supporting mechanical equipment,Production,Sales;import and export trade(Except for goods that the state restricts the company's operation and prohibits import and export);Hardware,bathroom,doors and windows,lamps,furniture,Research and development of building materials,Production,Sales;electrical tools,Adhesive Products Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the potential to be safe and effective for improving patient care. The company’s product pipeline includes new uses for approved drugs and new molecular entities (“NMEs”) for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. Central to the company’s successful clinical development programs are its strong relationships with clinicians, academic medical centers, regional hospitals and specialized product and service providers. A phase II clinical development program is underway in addition to sponsored basic, translational and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.